Last updated: 3 months ago
InflaRx N.V. Financial Report: $30M Capital Raise via 6-K Filing
Explore InflaRx N.V.'s latest 6-K filing detailing a $30M capital raise, including offering specifics and underwriter agreements.
Posts With Tag InflaRx N.V.
Showing 1 - 2 of 2 Posts
Last updated: 4 months ago
InflaRx N.V. Secures EU Approval for GOHIBIC®: A Game Changer for ARDS Treatment
InflaRx N.V. announces EU marketing authorization for GOHIBIC® to treat SARS-CoV-2-induced ARDS, marking a significant milestone in respiratory care. Learn more about this groundbreaking approval.